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A B S T R A C T
In this paper we present a fast model system for monitoring the recrystallization of quench-cooled
amorphous xylitol using Raman spectroscopy and wide-angle X-ray scattering. The use of these two
methods enables comparison between surface and bulk crystallization. Non-ordered mesoporous silica
micro-particles were added to the system in order to alter the rate of crystallization of the amorphous
xylitol. Raman measurements showed that adding silica to the system increased the rate of surface
crystallization, while X-ray measurements showed that the rate of bulk crystallization decreased. Using
this model system it is possible to measure fast changes, which occur in minutes or within a few hours.
Raman-spectroscopy and wide-angle X-ray scattering were found to be complementary techniques
when assessing surface and bulk crystallization of amorphous xylitol.
ã 2016 Elsevier B.V. All rights reserved.
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Today, poor aqueous solubility is a common problem when
developing new drug products. There are several approaches to
deal with solubility issues, such as formation of salts or prodrugs,
reducing the particle size or rendering the drug into a disordered
state (Hancock and Zograﬁ, 1997; Yu, 2001). Amorphous sub-
stances have a solubility superior to their crystalline counterparts
due to their higher levels of molecular disorder, free energy and
molecular mobility. The beneﬁcial properties of amorphous drug
substances are counterweighted by their inherent physical
instability and tendency to undergo solid-state changes to reach
the most stable crystal form.
Recrystallization from the amorphous state can take anything
from hours to years. Considerable effort and resources have been
invested in trying to achieve amorphous formulations with high* Corresponding author at: Division of Pharmaceutical Chemistry and Technolo-
gy, Faculty of Pharmacy, University of Helsinki, P.O. Box 56 (Viikinkaari 5E), FIN-
00014 University of Helsinki, Finland.
E-mail address: emmi.palomaki@helsinki.ﬁ (E. Palomäki).
http://dx.doi.org/10.1016/j.ijpharm.2016.04.074
0378-5173/ã 2016 Elsevier B.V. All rights reserved.enough stability to ensure sufﬁcient physical stability of the active
pharmaceutical ingredient throughout the shelf life of the ﬁnal
product. Still, a complete understanding of the crystallization of
amorphous solids has not been achieved (Laitinen et al., 2013;
Bhugra and Pikal, 2008). Typical stability studies of pharmaceut-
icals take several months to complete, and in order to facilitate the
development of drug products to the market there is a need to be
able to rapidly screen the physical stability challenges of
amorphous drugs.
It has been shown that the surface crystallization is more rapid
than bulk crystallization in amorphous glasses aged below their
glass transition temperature (Zhu et al., 2010, 2008; Wu et al.,
2007; Wu and Yu, 2006; Yu, 2016). The reason for this can not only
be found in the higher molecular mobility of surface molecules
compared to bulk molecules, but also in the more pronounced
structural relaxation of the surface as compared to the bulk
(Hasegawa et al., 2009). When the temperature exceeds the glass
transition temperature, the viscosity of the sample decreases, and
surface diffusion of molecules is disturbed by viscous ﬂow of the
material (Yu, 2016). This interrupts surface crystal growth, and as
bulk diffusion is simultaneously promoted the difference between
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smaller.
Raman spectroscopy is a method commonly used to identify
amorphous systems and quantify the amount of crystalline content
(Chieng et al., 2011; Strachan et al., 2007). The method provides
chemical information of the investigated molecules, and in
addition Raman spectroscopy also provides information on
inter-molecular interactions, which enables quantifying different
solid states of substances. Crystalline content in amorphous
samples has been detected down to 1% using Raman spectroscopy
(Strachan et al., 2007). Raman spectroscopy is non-invasive, non-
destructive, rapid and requires no sample preparation (Chieng
et al., 2011), which makes it ideal for real-time monitoring of solid-
state changes in pharmaceutical systems.
Powder X-ray diffraction is the most frequently used technique
in solid-state analysis, and it is often combined with a spectro-
scopic method for complementary information (Chieng et al.,
2011). Wide-angle X-ray scattering has been used to study the
crystal structure of pharmaceutically active substances, excipients
and drug products (Dong and Boyd, 2011) and is capable of
detecting crystalline content in amorphous systems in amounts
comparable to Raman spectroscopy (Paudel et al., 2015). It does not
provide chemical information on the sample, but readily provides
information on the structure of the studied material, and is able to
distinguish molecularly ordered and disordered material (Chieng
et al., 2011). In analysis of amorphous systems, WAXS is an indirect
method, since it detects lack of order rather than disorder.
In the present study, the crystallization rate of amorphous
xylitol was studied. Xylitol is a crystalline pentitole with only one
reported stable polymorphic form (Carson et al., 1943; Diogo et al.,
2007). Curiously enough, xylitol is an example of a substance with
a polymorphic form going extinct, since the stable orthorhombic
form has completely superseded over the metastable monoclinic
form (Dunitz and Bernstein, 1995). Xylitol has a relatively low glass
transition temperature of 24 C (Talja and Roos, 2001), and it
recrystallizes readily in room temperature. To alter the rate of
crystallization, non-ordered mesoporous silica (Syloid 244FP) was
added to the system in the present study. According to the
manufacturer, Syloid 244FP has large surface area of 350 m2/g, pore
size of 15–20 nm and pore volume of 1.6 ml/g. It has previously
been shown to increase the solubility of drug substances by
allowing them to maintain an amorphous state by conﬁnement inFig. 1. Sample holder. The 2 mm thick sample (ø 15 mm) is enclosed between two sheet
geometry and wide angle X-ray scattering is measured with perpendicular transmissiopores and molecular level interaction between the carrier particles
and drug substance (Kinnari et al., 2011; Limnell et al., 2011).
The aim of the present study was to investigate whether xylitol
can be used as a model substance to study rapid solid-state
changes. Furthermore, the study set out to see whether Raman
spectroscopy and wide-angle X-ray scattering could be used in
studying the recrystallization of amorphous xylitol. The crystal-
linity and crystallization rate results from Raman measurements
were compared with the wide-angle X-ray scattering results.
2. Materials and methods
2.1. Sample preparation
In the present study crystalline xylitol (University Pharmacy,
Helsinki, Finland) was used as a model substance. Non-ordered
mesoporous silica (Syloid 244FP, Grace GmbH & Co., KG, Germany)
was used to modify the crystallization rate of amorphous xylitol.
The substances were kept in a zero-humidity desiccator for a
minimum of two weeks prior to the experiments. Amorphous
xylitol was prepared by melting the crystalline powder on a hot
plate set at 180 C, which is well above the melting point of xylitol
(92–96 C) but clearly below its boiling point (215–217 C). The
melt was quench-cooled in liquid nitrogen and roughly ground
while submerged in liquid nitrogen. In samples comprised of
xylitol and 10% (m/m) of silica, Syloid 244FP was added to the melt
and thoroughly mixed prior to quench cooling and grinding as
described above. The amount of sample was 1.35 g in both cases.
The liquid nitrogen-sample suspension was transferred into a
sample holder and the liquid nitrogen was left to evaporate, and,
upon complete evaporation, the solid samples were enclosed
between two sheets of 6 mm thick Mylar ﬁlm in order to insulate
them from ambient humidity (Fig. 1). To avoid exposure to
atmospheric moisture and oxygen, all the steps of the sample
preparation following melting and mixing were performed in a dry
nitrogen atmosphere. The ﬁnal samples had a thickness of 2 mm
and a diameter of 15 mm. The lag-time between complete
evaporation of the liquid nitrogen and initiation of Raman and
wide-angle X-ray scattering measurements was no more than
4 min in all experiments. The sample holder was designed to
accommodate both Raman and X-ray measurements. The ibupro-
fen (Boots Pharmaceuticals, UK) and F-indomethacin (Orions of 6 mm thick Mylar ﬁlm. Raman-spectroscopy is performed using backscattering
n geometry.




The recrystallization of amorphous samples was measured
using Raman spectroscopy. The Raman spectra were collected
using a Raman RXN1-PhAT-785-D spectrometer (Kaiser, USA)
equipped with a PhAt system probe head (Kaiser optical systems,
Inc., USA). A 20-mW laser source at 785 nm was used (Raman
RXN1-PhAT-785-D, Kaiser aerospace & electronics company, USA).
The used spectrometer differs from confocal Raman spectrometry
by having a less powerful laser source, which saves the sample
from heating. Offset-signals were detected to allow better
detection of crystallinity of inhomogeneous sample. One mea-
surement consists of three averaged spectra.
In the present study, the Raman spectrometer laser covers a
relatively large area (6 mm in diameter). This minimizes the
spectrometer’s sensitivity to the exact positioning or the possible
inhomogeneity of the sample (Johansson et al., 2005; Paudel et al.,
2015). Additionally, the used laser power is relatively small, which
reduces the heat load of the sample. Collecting also spatially offset
scattering allows deeper detection into sample, since photons
generated in the bulk of the sample migrate laterally before
emission from the sample (Paudel et al., 2015; Matousek et al.,
2005).
The Raman shift recorded was between 100 cm1 and
1920 cm1, but only Raman shifts between 200 cm1 and
1800 cm1 were used because of inaccuracy in the edges of the
Raman shift area. The measurement has an integration time of 2 s
and one measurement was the result of three averaged scans.
During the recrystallization experiments spectra were collected in
ambient conditions with 1-min intervals for 6 h. During the Raman
measurements the ambient relative humidity was between 21 and
36% and the ambient temperature between 20.1 and 21.6 C. InFig. 2. Pretreatment ﬂow caddition, recrystallization was performed in an elevated tempera-
ture of 28.5–29.5 C and relative humidity of 19–25% correspond-
ing to the conditions of the WAXS experiments. In these
experiments Raman spectra were collected with 5-min intervals
as described above. All recrystallization experiments were
performed in triplicate.
Samples of xylitol and xylitol-syloid dispersions were prepared
for visual inspection with a microscope. In addition, samples from
the ﬁnal product were placed on an object glass, molten onto the
glass and quench cooled in liquid nitrogen before visual inspection
using a microscope.
2.2.2. Spectral pretreatment and partial least squares modeling
The spectra were subjected to different combinations of
preparations (Fig. 2). The spectra were treated using baseline
correction, Savitzky-Golay-smoothing, Standard Normal Variate
(SNV), Multiplicative Scatter Correction (MSC), and 1st and 2nd
derivatives were constructed. All spectral pretreatment, excluding
MSC were performed using MATLAB (MatLab R2014b, MathWorks
Inc., Natick, Massachusetts, The United States). The baseline
corrections were done with the function msbackadj with a
windowsize and stepsize of 25. MSC was done using SimcaP
10.5 (Umetrics AB, Umeå, Sweden).
Reference samples with varying amorphous-crystalline ratios
were prepared by adding known amounts of crystalline xylitol into
the amorphous xylitol – liquid nitrogen suspension. The reference
samples did not contain silica. The amounts of crystalline xylitol in
the reference samples were 0 (n = 5), 10 (n = 3), 25 (n = 3), 40 (n = 3),
50 (n = 5), 60 (n = 3), 75 (n = 3), 90 (n = 3) and 100% (n = 5). All
individual reference samples were measured in three times.
The xylitol spectra from samples with known amounts of
crystalline content were used as reference spectra in the partial
least squares (PLS) modeling. Raman shifts of 835.2–1145.4 cm1
were used, which cover most of the strong and mild characteristic
peaks in the spectrum and are relatively mildly affected by
ﬂuorescence. The choice of the Raman shift area was based on thehart of Raman spectra.
74 E. Palomäki et al. / International Journal of Pharmaceutics 508 (2016) 71–82peaks growing during crystallization and the characteristic
spectral features described by de Veij et al. (2009). The selected
range covers the in-phase n(CCO) stretching vibration at 872 cm1
and a group of peaks in the region between 1000 and 1150 cm1
representing the out-of-phase n(CCO) stretching vibration. The
correlation coefﬁcient R2 and the predictive strength Q2 were used
to evaluate the PLS-models.
2.2.3. Penetration depth of Raman scattering
The penetration depth of the Raman measurements was
studied measuring a layered structure consisting of a 2 mm thick
layer of amorphous xylitol or amorphous xylitol-silica dispersion,
1 mm of ibuprofen and a thick layer of g-indomethacin (Fig. 3a). All
layers were separated using Mylar ﬁlm. Spectra were collected at 0,
3 and 6 h from sample preparation to ensure complete recrystalli-
zation of the amorphous xylitol.
To study the extent of over-representation of the sample
surface, a sample containing 1 mm of crystalline xylitol and 1 mm
of ibuprofen (Fig. 3b) was studied. Raman spectra were collected
from both sides of the bilayer system in triplicate.
2.2.4. Wide-angle X-ray scattering (WAXS)
A Rigaku rotating-anode based X-ray set-up built at the
University of Helsinki (Kontro et al., 2014) was used for the WAXS
measurements. The samples were measured with perpendicular
transmission geometry in ambient temperature using Cu Ka1
wavelength (0.1541 nm). The beam size for the WAXS measure-
ments was 1 mm2 because a larger beam size would cause
signiﬁcant broadening of the diffraction peaks. In order to obtain aFig. 3. Depth of detection of the Raman-spectrometer used in the present study. (a) Rama
the spectrum measured of a layered system consisting of 2 mm of aXYL and 1 mm of IBU
(cXYL), ibuprofen (IBU) and a layered system consisting of 1 mm of cXYL and IBU meagood temporal resolution, a Pilatus 1 M detector was used and
exposures of 5 or 15 s were measured continuously over the
experiment (15 min for the crystalline xylitol reference, 90 min for
amorphous xylitol and 150 min for the amorphous xylitol
combined with 10-weigth percent silica). These exposures were
averaged over a time period of 60 s to improve signal-to-noise
ratio. Each averaged exposure was corrected as described in Dixon
et al. (2015). The ambient relative humidity was between 19.2 and
31.3% and the ambient temperature was between 28.7 and 29.3 C
during the measurements.
An amorphous xylitol scattering pattern was obtained from the
average of the ﬁrst three minutes of the amorphous xylitol
measurement. A crystalline xylitol model was obtained by reading
in peak positions and relative heights from the crystalline xylitol
measurement. A scattering pattern obtained from a separate
measurement of pure silica and the amorphous xylitol scattering
pattern were used to assess the contribution of silica in the xylitol-
silica sample. Least-squares ﬁtting was used to assess the relative
scattering contribution of the mesoporous silica (13%). The relative
amount of silica was assumed constant and this contribution was
subtracted from all the data points of the xylitol-silica measure-
ments. After the subtraction, the corrected scattering data
represents only the xylitol component.
The crystallinity value was obtained using least-squares-ﬁtting
of a linear superposition of the sharp diffraction peaks (modeled as
Gaussian) and the amorphous xylitol scattering pattern. To account
for small changes in sample position, crystallite sizes and
crystalline structure, peak positions were allowed to vary 0.5 in
position, 30% in relative height and 50% in peak width. The xylitoln spectra of amorphous xylitol (aXYL), ibuprofen (IBU), g-indomethacin (gIMC) and
 on a thick layer of gIMC (aXYL-IBU- gIMC); (b) Raman spectra of crystalline xylitol
sured with cXYL or IBU above (cXYL-IBU and IBU-cXYL, respectively).
E. Palomäki et al. / International Journal of Pharmaceutics 508 (2016) 71–82 75crystallinity value was then calculated from the areas under the
sample intensity curve Ixylitol and the amorphous contribution Iam
as














The xylitol crystallinity values were normalized with the
average crystallinity value of the crystalline xylitol measurement.
2.2.5. Differential scanning calorimetry
The solid state of the raw materials, freshly prepared samples
and end products were tested using differential scanning
calorimetry (DSC; DSC823e, Mettler-Toledo Inc., Switzerland).
The samples were cooled to 50 C and then heated to 0 C. After
that, the samples were re-cooled to 50 C and heated up to 140 C.
The heating was performed with a heating rate of 10 C/min. The
amounts of freshly prepared samples were 10.55 mg for the
amorphous sample, 5.05 mg for the amorphous xylitol-silica
sample and 7.90 mg for the crystalline sample. The samples
measured 6 h after preparation had masses of 5.63 and 5.62 mg for
xylitol and xylitol-silica dispersion, respectively.
3. Results and discussion
3.1. Raman spectrometry
The Raman-spectrum of amorphous xylitol differed from that of
crystalline xylitol in ways typical to an amorphous spectrum
(Fig. 4), i.e. peak broadening and loss of detail in the spectral
structure (e.g. Chieng et al., 2011; Ward et al., 2005). In their study
on amorphous sorbitol, Ward et al. (2005) used the full-width at
half-maximum of the peak caused by CCO-stretching to distin-
guish between amorphous and crystalline sorbitol, but they did
not, however, quantify the amount of crystalline and amorphous
sorbitol. The similarity in peak positions and overlapping features
did not permit assessing crystallinity using peak intensities, areasFig. 4. Typical Raman spectra of amorphouor full-width at half maximum in the present study, but the
spectral features were distinct enough to allow quantiﬁcation
using PLS-modeling, as described by Johansson et al. (2005). As
peaks merged in the spectrum of amorphous xylitol and there were
overlapping peaks in the spectra of crystalline and amorphous
xylitol, using a wider wavenumber range in modeling was justiﬁed
(Savolainen et al., 2007).
When monitoring the crystallization of amorphous xylitol using
Raman (Fig. 5), the spectrum of the initial state of the sample
corresponds to that of amorphous xylitol. The peak intensity of the
spectrum decreased until no distinct spectral features were
noticed at 5 min at T = 21 C, after which the characteristic spectral
features of crystalline xylitol gradually emerge in the spectra as the
xylitol crystallizes. Visual inspection of the system showed that the
amorphous form was opalescent after sample preparation. The
opalescence gradually reduced and the sample became clear, until
the opalescence gradually reoccurred as the crystallization
progressed. The intermediate region lacking distinct spectral
features between having amorphous substance and recrystalliza-
tion could be due to formation of a rubbery state, seen as increased
clarity of the sample, as the measurement was done in temper-
atures clearly above the glass transition temperature of xylitol.
When studying the penetration depth of Raman, features of the
spectral pattern of ibuprofen (peaks at 850, 875, 898 and 914 cm1)
were detected through 2 mm of amorphous xylitol and features of
g-indomethacin (peak at 1689 cm1) were detected through a
3 mm thick sample consisting xylitol and ibuprofen (Fig. 3a). This
indicates that the Raman spectrometer used in the present study
was able to detect changes from all depths of the 2 mm thick xylitol
samples. The intensity of the peak at 1689 cm1 in the Raman
spectrum of g-indomethacin did not depend on whether it was
detected through the fully amorphous or the crystalline xylitol,
indicating that the penetration depth was unaffected by the solid
state of xylitol. The inclusion of 10% (m/m) of silica dispersed in the
xylitol did not affect the outcome of the penetration depth studies.
When studying the xylitol-ibuprofen bilayer system, the upper-
most sample was clearly overrepresented, indicating that even
though the whole sample is represented in the Raman spectra ins (black) and crystalline xylitol (gray).
Fig. 5. Crystallization of amorphous xylitol measured with Raman spectroscopy at T = 21 C. The spectra shown are taken with 4-min intervals from 0 to 20 min and in 10-min
intervals from 20 to 300 min.
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(Fig. 3b).
3.2. Multivariate modeling
PLS-models were built using the Raman spectra of reference
samples with known degrees of crystallinity. The best model was
achieved from 2nd derivatives of MSC-corrected spectra, although
2nd derivatives of SNV-corrected spectra produced an almost
equally good model. The models had three components and R2 and
Q2-values of 0.972 and 0.970 and 0.971 and 0.969 respectively. It is
known that Raman-spectra are affected by variations in particle
size, sample packing, ﬂuorescence, instrument reproducibility and
intra- and interday variatons in intensity (Heinz et al., 2007;
Pellow-Jarman et al., 1996). The Raman-spectra in the present
study had ﬂuctuations in intensity and baseline variation, whichFig. 6. Typical WAXS intensity curves of amorphouexplains the suitability of the commonly used MSC, SNV and 2nd
derivatization as pretreatment methods (Johansson et al., 2005;
Strachan et al., 2007; Rinnan et al., 2009). 2nd derivatives remove
both baseline shifts and linear trends, whereas MSC is capable of
removing both additive and multiplicative errors of spectra
(Rinnan et al., 2009). MSC requires an external reference spectrum,
most often the average of the calibration set. Since MSC and SNV
often produce very similar outcomes as in this case (Rinnan et al.,
2009), and SNV uses the average of the sample spectrum for
normalization, the model built from 2nd derivatives of SNV-
treated spectra could be used in real-time monitoring of
crystallization as described by Savolainen et al. (2007).
The effect of the mesoporous silica on the Raman-spectrum of
xylitol was examined. In the Raman spectrum of Syloid 244FP there
were no distinct peaks, but areas with broad increases in intensity
similar to local baseline shifts. In the wavenumber area used fors xylitol (black) and crystalline xylitol (gray).
Fig. 7. Crystallization of amorphous xylitol measured with WAXS. Diffraction patterns shown were taken in 1-min intervals for 30 min.
E. Palomäki et al. / International Journal of Pharmaceutics 508 (2016) 71–82 77analysis in the present study the effect of Syloid 244FP on the
spectrum was similar to that of a slightly elevated baseline.
3.3. Wide angle X-ray scattering (WAXS)
In the diffractograms from WAXS the crystalline sample showed
a typical diffraction pattern of orthorhombic xylitol when
compared with data from the Cambridge Crystallographic Data
Centre (CCDC), whereas the amorphous counterpart showed a
characteristic amorphous halo (Fig. 6).
When studying the crystallization of amorphous xylitol using
WAXS the ﬁrst crystalline peaks emerged after ﬁve minutes,
followed by a rapidly increasing relative contribution of crystalline
peaks of the orthorhombic form of xylitol (Fig. 7). The positions of
the peaks did not change during the experiment, indicating that
the unit cell dimensions of crystalline xylitol did not change.
3.4. Recrystallization of xylitol and xylitol-silica solid dispersions
The recrystallization rate of amorphous xylitol-silica disper-
sions was higher than the recrystallization rate of amorphousFig. 8. Averaged crystallization curves of the Raman measurements for amorphous xylito
and black line). (a) ambient conditions (T = 20.1–21.6 C and RH% = 21–36) (b) elevated xylitol measured with Raman-spectrometry (Fig. 8). The replicate
measurements were performed in slightly different temperatures,
which might explain observed between measurements, since
crystallization is known to be temperature dependent (Bhugra and
Pikal, 2008). In the present study, increasing the temperature
caused the rate of crystallization to increase as measured with
Raman. Increasing the temperature increases molecular motion
and reduces viscosity, which both favor crystallization (Bhugra and
Pikal, 2008; Yu, 2016). When the temperature was increased from
T = 21 C to T = 29 C, the difference in rate of crystallization
between pure xylitol and xylitol-silica dispersion became less
signiﬁcant. This can be explained by the higher temperature and
lower viscosity of the super-cooled liquid having a more
pronounced impact on bulk crystallization than on surface
crystallization.
The recrystallization of xylitol was faster in T = 29 C compared
to ambient conditions of T = 21 C (Figs. 8 and 9). This can be
attributed to the temperature dependence of crystal growth
(Bhugra and Pikal, 2008), since the ambient temperature during
Raman measurements in ambient conditions was clearly lower
than during the WAXS-experiments and Raman experiments inl sample (black dots and gray line) and amorphous xylitol-silica dispersion (gray dots
temperature (T = 28.5–29.5 C and RH% = 19–25%).
Fig. 9. Crystallization of amorphous xylitol sample (black) and amorphous xylitol–silica mixture (grey) measured with WAXS.
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crystallization was slower for the solid dispersion, opposite to the
Raman measurements (Fig. 9). When recrystallization of xylitol in
T = 29 C was measured using Raman, the recrystallization rate of
pure xylitol was comparable to that measured using WAXS
(Figs. 8b and 9). The rate of crystallization was higher for
xylitol-silica dispersions measured with Raman as compared to
WAXS. Bulk diffusion is promoted over surface diffusion at
temperatures above Tg while surface diffusion becomes instable
due to viscous ﬂow on the surface (Yu, 2016). Still, even at elevated
temperatures, Raman measurements showed differences com-
pared to WAXS that could be attributed to surface crystallization,
since the measurement geometry of the Raman measurements
favors detection of surface events.
The different effects of the mesoporous silica on the crystalli-
zation rate of xylitol observed with Raman spectrometry and
WAXS can be explained by three different factors with an additive
effect on the measurement outcome. Firstly, the difference in
measurement setup between Raman and WAXS is expected to
affect the result, as the Raman measurements were done with a
backscattering geometry while the WAXS measurements were
done with perpendicular transmission geometry. The results from
Raman spectroscopy thus more pronouncedly show crystallization
events at or near the surface of the sample, as described by Priemel
et al. (2012). The ﬁndings regarding penetration depth in the
present study also conﬁrm that the surface was overrepresented in
the results obtained using Raman compared to those from WAXS-
measurements (Fig. 3a and b).
Secondly, Priemel et al. (2012) showed that nanocrystalline
indomethacin was detected as crystalline when using Fourier
transform attenuated total reﬂectance spectroscopy (FT-ATR-IR)
but amorphous when using X-ray powder diffractometry (XRPD).
Vibrational spectroscopy, such as IR- or Raman spectroscopy,
shows both intra- and intermolecular vibrations and therefore
detects very short-range disorder, whereas WAXS detects lack of
order on a crystallite or particle level. Thus, WAXS cannot
deﬁnitively distinguish whether the sample is amorphous ornano-crystalline, but with insufﬁcient long-range order (Bates
et al., 2006). Ueda et al. (2014) found that the rate of crystallization
of amorphous indomethacin was faster when measured using
Raman compared with XRPD. They found that Raman has a lower
level of detection than XRPD, possibly due to nano-crystalline
material and crystal nuclei appearing amorphous using XRPD but
are detectable using Raman, as also described by Savolainen et al.
(2009). Also Tian et al. (2007) reported underestimation of the
level of crystallinity of amorphous carbamazepine compacts using
XRPD compared to Raman spectroscopy. They attributed the
variation in crystallinity between methods to differences in
diffraction patterns of the calibration samples used in the models
to describe degree of crystallinity and the crystallized drug on the
compact surfaces, caused by decreased crystal size and differences
in crystal morphology and preferential orientation.
Thirdly, the difference might arise from differences in
crystallization rate on the surface and in the bulk of the samples.
Tian et al. (2007) analyzed the surface of carbamazepine compacts
and ground compacts. The results show higher degrees of
crystallinity on the surface of the compacts that in ground
compacts both using Raman and XRPD, indicating that the higher
crystallinity detected using Raman could be due to the crystalliza-
tion itself being more pronounced on the compact surface.
Crystallization on the surface of amorphous particles has been
reported to be considerably faster than in the bulk using
griseoﬂuvin, indomethacin and nifedipine (Zhu et al., 2010,
2008; Wu et al., 2007; Wu and Yu, 2006) due to surface molecules
having a higher mobility than molecules in the bulk. Zhu et al.
(2010, 2008) and Wu et al. (2007) showed that surface
crystallization could be suppressed by coating the sample surface.
Nanubolu and Burley (2012) and Wu et al. (2007) reported that the
crystallization kinetics of amorphous drugs changed when
covering the sample using a coverslip and thus restricting the
surface molecule mobility. In the present study the surface of the
sample was covered with Mylar-ﬁlm, but the coverage might not
have been close enough to restrict the mobility of the surface
molecules. One additional possible explanation for the pronounced
E. Palomäki et al. / International Journal of Pharmaceutics 508 (2016) 71–82 79surface crystallization of quench-cooled samples is heat transmis-
sion, since the surface of the sample presumably reaches room
temperature earlier than the bulk.
Watanabe et al. (2001) suspended silicon dioxide in molten
indomethacin and quench-cooled the mix to obtain an amorphous
sample. They found that silicon dioxide decreased the rate of
recrystallization of indomethacin due to interactions between
hydroxyl groups on the surface of the silicon dioxide particles and
the polar groups of indomethacin. Takeuchi et al. (2005) also
reported increased stability of solid dispersions containing
amorphous indomethacin and silica particles. Mártha et al.
(2014) studied co-grinding of clopidogrel and silicon dioxide,
and found that hydrogen bonding between silanol groups on the
surface of silicon dioxide particles and the drug molecule resulted
in a more stable amorphous structure. Hydrogen bonding similar
to that between hydroxyl groups on the carrier surface and drug
molecules could explain the decrease in crystallization rate in the
bulk of the xylitol-silica dispersion in the present study, consider-
ing the molecular structure of xylitol (Watanabe et al., 2001;
Takeuchi et al., 2005; Xu et al., 2013; Mártha et al., 2014).
One must also consider that when a foreign surface is added to
an amorphous system, heterogeneous nucleation is favored.
Hellrup and Mahlin (2011) investigated the stabilizing effect of
micro-sized ﬁller particles dispersed in freeze-dried sucrose. They
found that the ﬁller particles increased the glass transition
temperature, and concluded that the ﬁller particles decrease the
molecular mobility and hence stabilized the amorphous structure.
They also discovered small amounts of crystallinity in the sucrose
samples, but these did not alter the stability of the amorphous
state. Consequently they could not conﬁrm any stabilizing effects
due to increased heterogenous nucleation. Bhatt et al. (2015)
showed that in spray dried solid dispersions containing crystalline
mannitol and amorphous celecoxib, the mannitol acted as a surface
for heterogenous nucleation while at the same time being a
physical barrier preventing crystal growth, leading to a nano-
crystalline solid dispersion. The silica added to the xylitol in the
present study was expected to increase heterogenous nucleation,
rendering more pronounced nucleation and crystal growth in the
bulk of the sample, which could promote the formation of similar
structures as described by Hellrup and Mahlin (2011) and Bhatt
et al. (2015).
The surface crystallization studies by Zhu et al. (2010, 2008),
Wu et al. (2007), and Wu and Yu (2006) were completed with
amorphous substances below the glass transition temperature (Tg),
while the present study was performed above Tg. In the present
study, solid xylitol was molten and rapidly re-solidiﬁed in liquid
nitrogen at a temperature approximately 170 K below Tg. When a
melt is rapidly cooled to temperatures signiﬁcantly below Tg, the
molecular motion rapidly decreases and the system reaches a non-
equilibrium state (Yu, 2016). Below Tg, recrystallization of the
amorphous solid is emphasized on the particle surfaces. This is due
to the fact that molecules on the surface have more degrees of
freedom in their movement. This results in pronounced surface
diffusion of molecules causing crystal growth to occur laterally
along the surface and away from the surface. When the
temperature of the sample is increased to Tg and above, the
sample becomes rubbery, and the viscosity decreases with
growing temperature. This results in viscous ﬂow, which overrides
the effects of surface diffusion and, according to Yu (2016), leads to
lower and instable rates of surface crystallization. When the
viscosity of a super-cooled liquid decreases, the rate of crystalliza-
tion increases as the diffusion of molecules in the bulk is facilitated.
For crystal growth to occur effectively on the surface of an
amorphous glass, the surface needs to be rigid (Yu, 2016). Above Tg,
amorphous substances experience liquid-like ﬂow to some extent,
which might slow down the surface crystal growth and render itinstable. When silica is added to the system, the amount of free
surfaces increase and there is interaction between the silica
particles and xylitol-molecules, the viscosity of the melt increases
and as a result of the structural rigidiﬁcation that follows, the
prerequisites for surface crystallization might be promoted.
As reported by e.g. Riikonen et al. (2009) and Mellaerts et al.
(2008), substances loaded into the pores of porous carriers remain
amorphous if the pore is small enough to prevent the nuclei from
reaching the critical size for crystallization. Furthermore, even if
the pore size allows crystallization, the substance in close vicinity
to the pore walls remains amorphous. Mellaerts et al. (2008)
described how molten ibuprofen and itraconazole enter pores, and
found that the drug loading is impaired if the melt has a high
viscosity. In the present study, the xylitol melt seemed fairly
viscous, which could result in only small amounts of xylitol
entering the silicon dioxide pores. The lower level of crystallinity in
the xylitol-silica dispersions observed in Figs. 9 and 8b could be
explained by a small amount of xylitol being absorbed in the pores
of the silica and consequently remaining amorphous, while the
remaining xylitol outside the pores crystallizes.
Hellrup et al. (2015) studied the effect of a nanoﬁller (fumed
silica) on the recrystallization of spray-dried amorphous lactose.
They found that crystallization of amorphous systems is inhibited
through conﬁnement, i.e. entrapment within pores, compartmen-
talization, i.e. isolating amorphous compartments from each other
and rigidiﬁcation, i.e. molecular interactions between amorphous
molecules and solid surfaces. In the present study, xylitol melt is
mixed with non-ordered mesoporous silica. The results showed
signs of conﬁnement as described by e.g. Mellaerts et al. (2008) and
rigidiﬁcation as described by e.g. Watanabe et al. (2001), which in
combination could explain the lower crystallization rate and lower
level of end crystallinity observed using WAXS. Although the
volume fraction of silica in the system was rather high due to its
low density, no conclusive evidence indicating compartmentali-
zation of amorphous xylitol due to silicon dioxide particles as
described by Hellrup et al. (2015), Priemel et al. (2013) and Hellrup
and Mahlin (2011) could be found. Still, compartmentalization
leading to nanocrystalline structures having a resemblance to
those described by Priemel et al. (2012) and Bhatt et al. (2015)
cannot be conclusively ruled out solely based on Raman and WAXS
measurements.
Samples from xylitol and xylitol-silica dispersions were visually
inspected using a microscope following Raman-measurements
(Fig. 10a and c). The crystal size of xylitol-silica dispersions
(Fig. 10c) was clearly smaller than that of pure xylitol (Fig. 10a)
based on visual inspection. No conclusive evidence of varying
crystal size on the surface compared to the bulk could be observed.
Interestingly, when melting the xylitol sample mentioned onto an
object glass and quench-cooling the system in liquid nitrogen, no
signs of re-crystallization of parts of the sample could be observed
within days of sample preparation (Fig. 10b), and when crystalli-
zation occurred, the crystallite size was signiﬁcantly larger than in
the ground samples (Fig. 10a). A possible reason explaining the
difference in crystallization behavior is process-induced nucle-
ation in the ground sample. One could assume that this process-
induced nucleation would be highly surface-oriented simply due to
the nature of particle size reduction. The xylitol-silica dispersions
showed no delay in onset of crystallization when melting the
sample on an object glass and quench-cooling it in liquid nitrogen.
This further supports the hypothesis of process-induced surface
nucleation of ground xylitol samples and pronounced heteroge-
neous nucleation of xylitol-silica dispersions. The particle size of
the non-ground recrystallized xylitol-silica dispersion was similar
to the ground xylitol-silica dispersions on visual inspection. This
can be seen as evidence supporting the hypothesis of silica
suppressing crystals growing in size while still favoring
Fig. 10. Microscope images ground (a and c) and non-ground (b and d) xylitol (a and b) and xylitol-silica dispersion (c and d).
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(2012) and Bhatt et al. (2015).
The crystallization kinetics of the samples measured using
WAXS and one representative sample containing only xylitol and
one representative sample containing xylitol-silica dispersion
measured using Raman at T = 21 C as a function of time was
investigated using the Avrami-equation y ¼ 1  eðk ttð ÞnÞ, in which
y is the amount of crystalline substance, k describes the rate of
conversion, t is time, t is the lag time before onset of crystallization
and n describes the dimensionality of crystal growth (Tripathi
et al., 2015; Çelikbilek et al., 2012). As the crystallization curves
showed signs of a two-phased growth mechanism, only the initial
phase of rapid growth was investigated. If grinding was assumed to
cause site saturated nucleation, values of n = 1 would imply one-
dimensional growth, n = 2 two-dimensional growth and n = 3
three-dimensional growth. The Avrami constant n was found to
be approximately 2.0 in Raman measurements and approximately
2.8 WAXS measurements regardless of sample type. This can be
seen as further evidence supporting that Raman measures surface
crystallization, whereas WAXS measurements describe the overall
crystallinity.
In the present study WAXS and Raman at T = 21 C and T = 29 C
showed different end state crystallinity. The variation in level of
crystalline content in late stages of crystallization can be explained
through the effect of particle size on the crystallization rate when
surface crystallization is dominant over bulk crystallization. As
described in a recent review by Yu (2016), when the particle
surfaces are fully crystalline, the crystalline content plateaus and
the overall crystallization rate is dominated by signiﬁcantly slower
bulk crystallization. The level of the plateau is lower with
increasing particle size.
In Fig. 9, the overall rate of crystallization, as measured with
WAXS, seemed to clearly decrease for a prolonged period of time
towards the end of crystallization with pure xylitol as compared to
the xylitol-silica dispersion. This kinetic behavior is in line with the
description in Yu (2016) of a biphasic crystallization rate caused bysurface crystallization preceding bulk crystallization. Signs of
similar behavior can be seen in Raman measurements, but not as
clearly as with WAXS. Consequently, considering the difference in
measurement geometry, surface crystallization seems to be
dominant over bulk crystallization.
3.5. Thermal analysis
In the DSC-thermograms (Fig. 11), amorphous xylitol and
amorphous xylitol-silica dispersions both showed glass transition.
In the thermogram of amorphous xylitol, a wide exothermic
recrystallization peak was detected after the glass transition,
followed by a clear endothermic melting peak corresponding to the
melting point of xylitol (92–96 C). No differences in glass
transition were detected between the ﬁrst and second cooling of
the sample. The onset glass transition temperature (Tg) for
amorphous xylitol was 23.3 C, which corresponds well with
the value of 24.1 C for waterless xylitol reported by Talja and
Roos (2001). The slight difference could be explained with the
heating rate, which was 10 C/min in the present study and 5 C/
min in Talja and Roos (2001).
The Tg of xylitol-silica dispersions was 32.4 C, which is clearly
lower than that of waterless xylitol. Mellaerts et al. (2008) reported
a decrease in Tg of itraconazole loaded in mesoporous silica
particles, and attributed the decrease to conﬁnement of itracona-
zole in the pores of the carrier material and to the increased
surface-to-volume ratio of the adsorbed itraconazole phase. The
decrease of the glass transition temperature in the present study
could partially be attributed to conﬁnement of xylitol in the pores
of Syloid 244 FP. No melting peak was detected for the xylitol-silica
dispersion in the present study. Similar behavior was reported by
Kinnari et al. (2011). They studied itraconazole loaded Syloid
244FP, and explained the lack of melting peak to itraconazole being
amorphous. Mellaerts et al. (2008) found similar results, including
an absence of the crystallization peak as in the present study. Since
there was a broad exothermic peak in the DSC-thermogram
Fig. 11. Typical DSC thermograms of amorphous xylitol (black), mixture of amorphous xylitol and silica (light grey) and crystalline xylitol (dark grey, dashed).
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evaporation of water (e.g. Artiaga et al., 2005), and as Talja and Roos
(2001) found that water content has a signiﬁcant effect on the Tg of
xylitol, with a value of – 53 C reported for xylitol samples
containing 10% of water, the presence of water in the xylitol-silica
dispersions in the samples analyzed using DSC cannot be exluded.
Hellrup and Mahlin (2011) discovered that micro-sized ﬁller
particles stabilized freeze-dried amorphous sucrose. They found
that there is a critical relative humidity threshold, above which the
stabilizing effect of the ﬁller micro-particles was lost. The results in
the present study indicate that the xylitol-silica dispersions
studied with DSC contained some atmospheric water that most
likely condensed on the sample surface immediately after
evaporation of the liquid nitrogen, which was reﬂected in the
Tg. Although measures were taken to avoid water exposure during
the Raman and WAXS-measurements, complete absence of water
cannot be conﬁrmed. In addition to plasticizing the amorphous
sample and thus increasing molecular mobility (e.g. Andronis et al.,
1997), the water might inhibit the stabilizing effect of the silicon
dioxide particles as described by Hellrup and Mahlin (2011). After a
recrystallization time of 6 h, none of the samples in the present
study showed any signs of glass transition in the DSC-thermo-
grams, indicating that all samples were fully crystalline at the end
of Raman measurements.
4. Conclusions
Quench-cooled and cryo-ground amorphous xylitol recrystal-
lized rapidly in room temperature showing features of surface
crystallization, and could be used as a model system for rapid
recrystallization from the amorphous state. Introducing 10% (m/m)
of non-ordered mesoporous silica to the system decreased the
overall rate of crystallization in the sample, as detected by WAXS.
Furthermore, adding silica to the system seemed to facilitate
heterogeneous nucleation and decreased the crystal size of xylitol.
Raman spectroscopy can be used when studying the recrystal-
lization of amorphous xylitol. The amorphous form of xylitol and
crystalline content can be detected rapidly in seconds andaccurately even in trace amounts, which enables real-time
monitoring of crystallization. The Raman instrument in the
present study was capable of measuring on a depth more than 3
millimeters. Still, the surface is clearly overrepresented in the
signal, which enables monitoring surface crystallization of xylitol.
The transmission WAXS-setup used in the present study
enables making conclusions on the total crystallization rate of
the amorphous sample, consisting of both surface crystallization
and bulk crystallization, and is thus a valuable complement to the
surface-dominated Raman measurements. In addition, the WAXS-
setup allows relatively short integration times, which enables
accurate real-time monitoring of crystallization. Raman spectros-
copy and transmission WAXS provide valuable complementary
information in real-time monitoring of rapidly crystallizing
amorphous systems.
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